Close Menu

NEW YORK – Proteomics firm Somalogic said on Wednesday that it has closed a $121 million Series A funding round that it plans to use to expand and further commercialize its SomaScan platform and SomaSignal proteomic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.